Frazier has raised an $830M public life science fund. Here's how it plans to invest the cash

Frazier Healthcare Partners is expanding its investment activity, raising $830 million for its first fund dedicated to public life science companies. The targets? Small and mid-cap biotechs that are off the beaten path or recovering from a value-crushing setback.